Table 2. Effect of CD-3 on the activities of marker enzymes in the serum.
| Groups |
Parameters
|
|||
|---|---|---|---|---|
| ALT (U/L) | AST (U/L) | ALP (U/L) | γ-GT (U/L) | |
| Group 1 | 61.32 ± 1.80 | 81.65 ± 3.92 | 210.63 ± 3.90 | 35.66 ± 1.41 |
| Group 2 | 213.86 ± 4.25* | 204.97 ± 2.51* | 493.50 ± 8.08* | 195.12 ± 4.63* |
| Group 3 | 131.46 ± 7.93* | 156.28 ± 2.51* | 290.71 ± 6.08* | 111.81 ± 3.81* |
Group 1: Control; Group 2: NDEA/CCl4; Group 3: NDEA/CCl4/CD-3. Data represent the means ± SEM in each group. * P < 0.001 versus vehicle treated and NDEA/CCl4 or NDEA/CCl4/CD-3. Comparisons were made between Group 1 and Group 2 mice and between Group 2 and Group 3 mice.